• Joan Mannick on Rapamycin Longevity Series | Turning down mTOR to young levels may be good for aging

  • Jan 17 2024
  • Length: 1 hr and 22 mins
  • Podcast

Joan Mannick on Rapamycin Longevity Series | Turning down mTOR to young levels may be good for aging

  • Summary

  • Dr Joan Mannick is one of the world’s leading rapamycin and mTOR researchers in the longevity field. Joan has a background in academic medicine and is currently CEO at her own company Tornado Therapeutics where they focus on developing the next generation of mTOR inhibitors. One of the company goals is to create a mTOR inhibitor which is better than Rapamycin. Throughout the years Joan has made important discoveries in humans when it comes to finding a connection between mTOR inhibition and improvement of the aging immune system. In this podcast we are going to talk about her research, drug development, mTOR, rapamycin, rapalogs and other interesting longevity topics.

    Links

    https://www.tornado-tx.com

    Joan's LinkedIn

    Joan’s research publications

    Big thanks to TimePie for the research help for this episode

    Rapamycin resources

    Rapamycin.news

    Rapamycin Facebook group

    Rapamycin Reddit group

    Connect with Krister on:

    Twitter

    LinkedIn

    Instagram

    Disclaimer: The podcast is for general information and educational purposes only and is not medical advice for you or others. The use of information and materials linked to the podcast is at the users own risk. Always consult your physician with anything you do regarding your health or medical condition.

    Show More Show Less

What listeners say about Joan Mannick on Rapamycin Longevity Series | Turning down mTOR to young levels may be good for aging

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.